Latest Form 4 insider transactions

NYSE
Jonathan S Beatty, MD, Head of Advisor Services of Schwab Charles Corp, sold 1,000 shares of common stock on August 17, 2026 for $111.33 per share.
AMEX
Scott C Neils, CFO and Assistant Secretary of Xtant Medical Holdings, Inc., reported multiple transactions in common stock on August 15, 2026.
NYSE
Kevin Hillesland, SVP, Structured Finance of Gatx Corp, reported a transaction in 70 shares of common stock on August 15, 2026.
NASDAQ
Jason Lettmann, CHIEF EXECUTIVE OFFICER and a Director of Alx Oncology Holdings Inc, sold 2,230 shares of common stock on August 17, 2026 for $1.93 per share.
NASDAQ
Mauad Bruno Sousa, a Director of Aura Minerals Inc., purchased 11,000 shares of common stock on August 17, 2026 for $78.93 per share.
NASDAQ
Shelly Wong, SVP, FINANCE AND CAO of Alx Oncology Holdings Inc, sold 573 shares of common stock on August 17, 2026 for $1.93 per share.
NASDAQ
Gregory Wong, CFO of Quinstreet, Inc, sold 11,704 shares of common stock on August 18, 2026 for $20.44 per share.
NASDAQ
Alexandros Aldous, General Counsel of Chefs' Warehouse, Inc., sold 35,000 shares of common stock on August 14, 2026.
NASDAQ
Asmau Ahmed, a Director of Quinstreet, Inc, sold 25,000 shares of common stock on August 14, 2026.
AMEX
Sean E Browne, President and CEO and a Director of Xtant Medical Holdings, Inc., reported multiple transactions in common stock on August 15, 2026.
NASDAQ
Christina Polychroni, Chief Human Resources Officer of Chefs' Warehouse, Inc., sold 2,752 shares of common stock on August 14, 2026 for $112.00 per share.
NYSE
Timothy Gertsch, Chief Accounting Officer of agilon health, inc., reported a transaction in 17 shares of common stock on August 16, 2026.
NASDAQ
Najat Khan, CEO and President and a Director of Recursion Pharmaceuticals, Inc., reported a transaction in 80,498 shares of common stock on August 17, 2026.
NASDAQ
David Hallett, Chief Scientific Officer of Recursion Pharmaceuticals, Inc., reported a transaction in 26,657 shares of common stock on August 17, 2026.
NASDAQ
Ben R Taylor, Chief Financial Officer of Recursion Pharmaceuticals, Inc., reported a transaction in 25,018 shares of common stock on August 17, 2026.
NYSE
Susan M. Canning, SVP, CLO, Corporate Secretary of Hayward Holdings, Inc., sold 3,500 shares of common stock on August 17, 2026 for $15.06 per share.
NASDAQ
Christopher Pappas, President and CEO and a Director of Chefs' Warehouse, Inc., sold 100,000 shares of common stock on August 14, 2026.
NASDAQ
Ryan H Siurek, Chief Financial Officer of EverCommerce Inc., sold 16,812 shares of common stock on August 14, 2026 for $10.21 per share.
NASDAQ
Naama Falach Avrahamy, a Director of Maris Tech Ltd., received 35,495 shares of common stock on August 17, 2026.
NASDAQ
Matt Goldberg, CEO and President and a Director of TripAdvisor, Inc., reported multiple transactions in common stock on August 14, 2026.
NASDAQ
Gregory Sadikoff, Chief Accounting Officer of Energous Corp, received 22,567 shares of common stock on August 17, 2026.
NASDAQ
Peter M Weinberg, General Counsel of Energous Corp, received 22,667 shares of common stock on August 17, 2026.
NASDAQ
Giampaolo Marino, Chief S&G Officer of Energous Corp, received 43,100 shares of common stock on August 17, 2026.
NASDAQ
Mallorie Sara Burak, CEO & CFO and a Director of Energous Corp, received 146,266 shares of common stock on August 17, 2026.
NASDAQ
Israel Bar, Chief Executive Officer and a Director of Maris Tech Ltd., received 251,902 shares of common stock on August 17, 2026.
NASDAQ
Eric Richard Remer, a Director of EverCommerce Inc., sold 53,066 shares of common stock on August 14, 2026.
NASDAQ
Charles E Ryan, a Director of Nebius Group N.V., sold 50,000 shares of common stock on August 14, 2026.
NASDAQ
John D Baker Ii, a Director and 10% owner of Frp Holdings, Inc., purchased 9,146 shares of common stock on August 17, 2026.
NASDAQ
Michael Noonan, CFO & SVP of TripAdvisor, Inc., reported multiple transactions in common stock on August 14, 2026.
NASDAQ
William Heard, a Director of Anterix Inc., sold 46,400 shares of common stock on August 14, 2026 for $90.11 per share.